| Autor: |
Sudeepa Syamala, Nadia Boufaied, Eva Corey, R. Jeffrey Karnes, Massimo Loda, Avery S. Feit, Tarek Hallal, Shengqing Gu, X. Shirley Liu, Connor Bell, Henry W. Long, Sheila Weinmann, Yingtian Xie, Qin Tang, Giorgia Zadra, Xintao Qiu, Paloma Cejas, Myles Brown, Kai W. Wucherpfennig, Adrienne M. Luoma, David P. Labbé, Anna de Polo, Mark Pomerantz, Elai Davicioni, Ji-Heui Seo, Daniel E. Spratt, Janie Larocque, Edward M. Schaeffer, Leigh Ellis, Matthew L. Freedman, Yi Zhang, Yang Liu, Edward P. O’Connor |
| Rok vydání: |
2021 |
| Předmět: |
|
| DOI: |
10.1101/2021.04.23.441016 |
| Popis: |
c-MYC (MYC) is a major driver of prostate cancer tumorigenesis and progression. Although MYC is overexpressed in both early and metastatic disease and associated with poor survival, its impact on prostate transcriptional reprogramming remains elusive. We demonstrate that MYC overexpression significantly diminishes the androgen receptor (AR) transcriptional program (the set of genes directly targeted by the AR protein) in luminal prostate cells without altering AR expression. Importantly, analyses of clinical specimens revealed that concurrent low AR and high MYC transcriptional programs accelerate prostate cancer progression toward a metastatic, castration-resistant disease. Data integration of single-cell transcriptomics together with ChIP-seq revealed an increased RNA polymerase II (Pol II) promoter-proximal pausing at AR-dependent genes following MYC overexpression without an accompanying deactivation of AR-bound enhancers. Altogether, our findings suggest that MYC overexpression antagonizes the canonical AR transcriptional program and contributes to prostate tumor initiation and progression by disrupting transcriptional pause release at AR-regulated genes.STATEMENT OF SIGNIFICANCEAR and MYC are key to prostate cancer etiology but our current understanding of their interplay is scarce. Here we show that the oncogenic transcription factor MYC can pause the transcriptional program of the master transcription factor in prostate cancer, AR, while turning on its own, even more lethal program. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
